Endocannabinoid System & Psychosis Risk: Clinical Evidence
Comments Off on Endocannabinoid System & Psychosis Risk: Clinical Evidence
April 15, 2026
Clinical evidence highlights the role of the endocannabinoid system psychosis risk in first episode psychosis. Identifying risk factors early can improve treatment outcomes. This research supports coordinated care to reduce legal system involvement.
New Study Links Cannabis Use in Teens to Psychosis Risk
Comments Off on New Study Links Cannabis Use in Teens to Psychosis Risk
February 23, 2026
A major study highlights cannabis youth psychosis risk, showing that teen cannabis use increases chances of psychotic disorders later. The developing brain is vulnerable to THC effects, raising psychiatric concerns. This research urges caution and…
Cannabis Use Associated with Worse Working Memory – EMJ
Comments Off on Cannabis Use Associated with Worse Working Memory – EMJ
February 23, 2026
Heavy cannabis use working memory effects are linked to reduced brain activation during memory tasks. Dose, frequency, and cannabinoid profile influence cognitive outcomes. Medical patients using low-to-moderate doses face a different risk profile.